Psychedelic drugs, once highly stigmatized, are increasingly becoming part of our society’s conversations about mental health, therapy and well-being. And there’s momentum even in the staid world of Big Law.

Winston & Strawn associate Brett Waters has helped crack open the door with his advocacy on the subject. With the support of his firm, he launched a nonprofit organization advocating for legal reform to make psychedelic-assisted therapy available and affordable to all in the U.S.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]